Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02409329 · ClinicalTrials.gov registry record · NA
Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 512
- Enrollment target
NCT02409329 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 512 participants.
The verdict
NCT02409329, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 512 participants
- Enrollment target
Study Summary
This study evaluates a mobile phone-delivered intervention, called REACH (Rapid Education/Encouragement And Communications for Health), in supporting adults with type 2 diabetes in their self-management relative to a control group. The goal of this study is to determine if individually tailored content (based on the Information-Motivation-Behavioral Skills Model) delivered to the participant via text messages can improve the participant's glycemic control and adherence to diabetes medications. We will test whether our intervention improves adherence-related information, motivation, and behavioral skills and whether improving these mechanisms drives improvements in adherence and, in turn, glycemic control.
Interventions
- BEHAVIORAL REACH
- BEHAVIORAL Helpline and A1c results
- BEHAVIORAL REACH + FAMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2016-05-23 |
| Est. Completion | 2019-06-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02409329
The ClinicalTrials.gov registry entry for NCT02409329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 512 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which REACH is the first listed.
NCT02409329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02409329 about?
NCT02409329 is a clinical study titled "Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes". This study evaluates a mobile phone-delivered intervention, called REACH (Rapid Education/Encouragement And Communications for Health), in supporting adults with type 2 diabetes in their self-management relative to a control group. The goal of this study is to determine if individually tailored cont...
What is the current status of trial NCT02409329?
This trial is currently completed. It is a NA study. The enrollment target is 512 participants. The study started on 2016-05-23. Estimated completion is 2019-06-04.
What interventions are being tested in trial NCT02409329?
The interventions under investigation include: REACH (BEHAVIORAL), Helpline and A1c results (BEHAVIORAL), REACH + FAMS (BEHAVIORAL).
Who is sponsoring clinical trial NCT02409329?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.